Department of Neurology, 12239Emory University School of Medicine, Marcus Stroke & Neuroscience Center, 71741Grady Memorial Hospital, Atlanta, GA, USA.
Department of Neurology, 2202Cooper University Hospital Neurological Institute, Camden, NJ, USA.
Int J Stroke. 2022 Mar;17(3):331-340. doi: 10.1177/17474930211006304. Epub 2021 Apr 7.
The effect of time from stroke onset to thrombectomy in the extended time window remains poorly characterized.
We aimed to analyze the relationship between time to treatment and clinical outcomes in the early versus extended time windows.
Proximal anterior circulation occlusion patients from a multicentric prospective registry were categorized into early (≤6 h) or extended (>6-24 h) treatment window. Patients with baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 10 and intracranial internal carotid artery or middle cerebral artery-M1-segment occlusion and pre-morbid modified Rankin scale (mRS) 0-1 ("DAWN-like" cohort) served as the population for the primary analysis. The relationship between time to treatment and 90-day mRS, analyzed in ordinal (mRS shift) and dichotomized (good outcome, mRS 0-2) fashion, was compared within and across the extended and early windows.
A total of 1603 out of 2008 patients qualified. Despite longer time to treatment (9[7-13.9] vs. 3.4[2.5-4.3] h, < 0.001), extended-window patients ( = 257) had similar rates of symptomatic intracranial hemorrhage (sICH; 0.8% vs. 1.7%, = 0.293) and 90-day-mortality (10.5% vs. 9.6%, = 0.714) with only slightly lower rates of 90-day good outcomes (50.4% vs. 57.6%, = 0.047) versus early-window patients ( = 709). Time to treatment was associated with 90-day disability in both ordinal (adjusted odd ratio (aOR), ≥ 1-point mRS shift: 0.75; 95%CI [0.66-0.86], < 0.001) and dichotomized (aOR, mRS 0-2: 0.73; 95%CI [0.62-0.86], < 0.001) analyses in the early- but not in the extended-window (aOR, mRS shift: 0.96; 95%CI [0.90-1.02], = 0.15; aOR, mRS0-2: 0.97; 95%CI [0.90-1.04], = 0.41). Early-window patients had significantly lower 90-day functional disability (aOR, mRS shift: 1.533; 95%CI [1.138-2.065], = 0.005) and a trend towards higher rates of good outcomes (aOR, mRS 0-2: 1.391; 95%CI [0.972-1.990], = 0.071).
The impact of time to thrombectomy on outcomes appears to be time dependent with a steep influence in the early followed by a less significant plateau in the extended window. However, every effort should be made to shorten treatment times regardless of ischemia duration.
从中风发病到血栓切除术的时间对延长时间窗内的影响仍知之甚少。
旨在分析治疗时间与早期和延长时间窗内的临床结果之间的关系。
将多中心前瞻性登记处的近端前循环闭塞患者分为早期(≤6 小时)或延长(>6-24 小时)治疗窗。基线 NIHSS(国立卫生研究院卒中量表)≥10 分且颅内颈内动脉或大脑中动脉-M1 段闭塞以及发病前改良 Rankin 量表(mRS)0-1 分的患者(“DAWN 样”队列)作为主要分析的人群。在早期和延长窗内,以等级(mRS 变化)和二分法(良好结局,mRS 0-2)分析治疗时间与 90 天 mRS 的关系,并进行比较。
共有 2008 例患者中的 1603 例符合条件。尽管延长窗患者(n=257)的治疗时间更长(9[7-13.9]小时 vs. 3.4[2.5-4.3]小时,<0.001),但其症状性颅内出血(sICH;0.8% vs. 1.7%,=0.293)和 90 天死亡率(10.5% vs. 9.6%,=0.714)相似,90 天良好结局率(50.4% vs. 57.6%,=0.047)略低于早期窗患者(n=709)。在早期窗内,治疗时间与 90 天残疾呈正相关,无论是等级(调整后的比值比(aOR),≥1 分 mRS 变化:0.75;95%CI [0.66-0.86],<0.001)还是二分法(aOR,mRS 0-2:0.73;95%CI [0.62-0.86],<0.001)。但是,在延长窗内,治疗时间与 90 天残疾无相关性(aOR,mRS 变化:0.96;95%CI [0.90-1.02],=0.15;aOR,mRS0-2:0.97;95%CI [0.90-1.04],=0.41)。早期窗患者的 90 天功能残疾显著较低(aOR,mRS 变化:1.533;95%CI [1.138-2.065],=0.005),且良好结局的比例有升高趋势(aOR,mRS 0-2:1.391;95%CI [0.972-1.990],=0.071)。
血栓切除术治疗时间对结局的影响似乎与时间有关,早期影响明显,随后延长窗内影响程度较低。然而,无论缺血持续时间如何,都应尽最大努力缩短治疗时间。